FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140603866> ?p ?o ?g. }

• W2140603866 endingPage "366" @default.
• W2140603866 startingPage "360" @default.
• W2140603866 abstract "Objective: As Aspirin (ASA) has proven efficacy in preventing patients with CAD from complications related to cardiovascular diseases, most patients scheduled for CABG are treated with ASA therapy. Consequently, impaired haemostasis is a problem in the management of CABG patients. Clinical studies have shown that Aprotinin can reduce bleeding and the use of blood products by 50% in patients both with and without pre-operative ASA therapy. Concerning the combined effect of peri-operative low-dose ASA therapy and intra-operative high-dose Aprotinin therapy, the gathering of additional and prospective data seemed to be necessary. Methods: We conducted a double-blind two-centre randomised three-arm study in patients with elective primary CABG surgery. Three groups have been tested, comprising 119 patients in total (group A: ASA+Aprotinin, group B: placebo+Aprotinin, group C: placebo+placebo) to investigate a possible reduction of bleeding in Aprotinin treated patients. For all patients, thromboxane levels were used to identify ASA or placebo treatment. Results: The post-operative blood loss is significantly reduced by 21% after Trasylol® administration (B vs. C; P=0.009). The unexpected result of this study has been that the pre-treatment with ASA led to a further reduction of 18% (A vs. C; P<0.0001). The difference between the two Aprotinin groups (A and B) is significant (P=0. 01) in favour of ASA pre-treatment. Myocardial infarction (MI) had been diagnosed at levels of 1.8% in total (2/113), 2.6% (1/38) in group B and 3.2% (1/31) in group C. An additional blinded evaluation of ECG, enzyme levels and clinical status revealed `definite, probable and possible' MIs of 5% in group A, compared to 16% in group B and 13% in group C, thus providing no evidence for a higher risk of infarction by Aprotinin treatment. When comparing the ASA group to non-ASA pre-treatment, a strong trend towards a reduction in MI rate becomes obvious, from 15% to 5% in favour of the ASA pre-treatment (P=0.08). Concerning other peri-operative complications, no statistical difference between the groups could be detected. Conclusions: A reduction in post-operative blood loss in primary elective CABG surgery with intra-operative Aprotinin treatment could be confirmed. A low-dose ASA treatment combined with a high-dose aprotinin administration during surgery not only neutralised a potentially higher risk of bleeding, but did in fact reduce the post-operative blood loss. The protective effect of ASA on peri-operative MI has been evident through a reduction of MI rate in ASA treated patients." @default.
• W2140603866 created "2016-06-24" @default.
• W2140603866 creator A5027308245 @default.
• W2140603866 date "1998-10-01" @default.
• W2140603866 modified "2023-09-27" @default.
• W2140603866 title "Aprotinin counterbalances an increased risk of peri-operative haemorrhage in CABG patients pre-treated with Aspirin" @default.
• W2140603866 cites W1516463094 @default.
• W2140603866 cites W1951513130 @default.
• W2140603866 cites W1970218396 @default.
• W2140603866 cites W2022431054 @default.
• W2140603866 cites W2026039118 @default.
• W2140603866 cites W2035542600 @default.
• W2140603866 cites W2039164806 @default.
• W2140603866 cites W2043304436 @default.
• W2140603866 cites W2062839391 @default.
• W2140603866 cites W2064581888 @default.
• W2140603866 cites W2071650970 @default.
• W2140603866 cites W2087186913 @default.
• W2140603866 cites W2088333712 @default.
• W2140603866 cites W2090376664 @default.
• W2140603866 cites W2099069840 @default.
• W2140603866 cites W2115041325 @default.
• W2140603866 cites W2118414830 @default.
• W2140603866 cites W2152539895 @default.
• W2140603866 cites W2168424271 @default.
• W2140603866 cites W2253816243 @default.
• W2140603866 cites W2316166446 @default.
• W2140603866 cites W2325460018 @default.
• W2140603866 cites W2411298912 @default.
• W2140603866 cites W2412554034 @default.
• W2140603866 cites W2413550399 @default.
• W2140603866 cites W2414531805 @default.
• W2140603866 cites W2417100811 @default.
• W2140603866 cites W2417520422 @default.
• W2140603866 cites W2469316347 @default.
• W2140603866 cites W2801143877 @default.
• W2140603866 cites W3021384959 @default.
• W2140603866 cites W4244424204 @default.
• W2140603866 cites W4247309206 @default.
• W2140603866 cites W81396684 @default.
• W2140603866 doi "https://doi.org/10.1016/s1010-7940(98)00192-4" @default.
• W2140603866 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9845139" @default.
• W2140603866 hasPublicationYear "1998" @default.
• W2140603866 type Work @default.
• W2140603866 sameAs 2140603866 @default.
• W2140603866 citedByCount "39" @default.
• W2140603866 countsByYear W21406038662012 @default.
• W2140603866 countsByYear W21406038662015 @default.
• W2140603866 countsByYear W21406038662017 @default.
• W2140603866 countsByYear W21406038662018 @default.
• W2140603866 countsByYear W21406038662019 @default.
• W2140603866 crossrefType "journal-article" @default.
• W2140603866 hasAuthorship W2140603866A5027308245 @default.
• W2140603866 hasBestOaLocation W21406038661 @default.
• W2140603866 hasConcept C126322002 @default.
• W2140603866 hasConcept C141071460 @default.
• W2140603866 hasConcept C142724271 @default.
• W2140603866 hasConcept C204787440 @default.
• W2140603866 hasConcept C27081682 @default.
• W2140603866 hasConcept C2776641609 @default.
• W2140603866 hasConcept C2777628954 @default.
• W2140603866 hasConcept C2779036427 @default.
• W2140603866 hasConcept C2780799893 @default.
• W2140603866 hasConcept C3017583242 @default.
• W2140603866 hasConcept C42219234 @default.
• W2140603866 hasConcept C500558357 @default.
• W2140603866 hasConcept C71924100 @default.
• W2140603866 hasConceptScore W2140603866C126322002 @default.
• W2140603866 hasConceptScore W2140603866C141071460 @default.
• W2140603866 hasConceptScore W2140603866C142724271 @default.
• W2140603866 hasConceptScore W2140603866C204787440 @default.
• W2140603866 hasConceptScore W2140603866C27081682 @default.
• W2140603866 hasConceptScore W2140603866C2776641609 @default.
• W2140603866 hasConceptScore W2140603866C2777628954 @default.
• W2140603866 hasConceptScore W2140603866C2779036427 @default.
• W2140603866 hasConceptScore W2140603866C2780799893 @default.
• W2140603866 hasConceptScore W2140603866C3017583242 @default.
• W2140603866 hasConceptScore W2140603866C42219234 @default.
• W2140603866 hasConceptScore W2140603866C500558357 @default.
• W2140603866 hasConceptScore W2140603866C71924100 @default.
• W2140603866 hasIssue "4" @default.
• W2140603866 hasLocation W21406038661 @default.
• W2140603866 hasLocation W21406038662 @default.
• W2140603866 hasOpenAccess W2140603866 @default.
• W2140603866 hasPrimaryLocation W21406038661 @default.
• W2140603866 hasRelatedWork W1984595407 @default.
• W2140603866 hasRelatedWork W1989339005 @default.
• W2140603866 hasRelatedWork W2048260363 @default.
• W2140603866 hasRelatedWork W2061558054 @default.
• W2140603866 hasRelatedWork W2101077504 @default.
• W2140603866 hasRelatedWork W2118828132 @default.
• W2140603866 hasRelatedWork W2128088799 @default.
• W2140603866 hasRelatedWork W2354417434 @default.
• W2140603866 hasRelatedWork W2402440863 @default.
• W2140603866 hasRelatedWork W2332968747 @default.
• W2140603866 hasVolume "14" @default.
• W2140603866 isParatext "false" @default.
• W2140603866 isRetracted "false" @default.

• next